Your browser doesn't support javascript.
loading
Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report.
Urushibara, Masayasu; Ishizaka, Kazuhiro; Matsutani, Noriyuki; Takahashi, Mikiko; Nagata, Masakazu; Okumura, Taisuke; Matsumoto, Yuuki; Tatsuoka, Shinichiro; Nenohi, Tsunehiro; Amemiya, Takumasa; Shimizu, Yohei; Shirakawa, Takeshi; Kato, Daisuke.
Afiliación
  • Urushibara M; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan. urushibara0383@med.teikyo-u.ac.jp.
  • Ishizaka K; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Matsutani N; Department of Surgery, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Takahashi M; Department of Diagnostic Pathology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Nagata M; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Okumura T; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Matsumoto Y; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Tatsuoka S; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Nenohi T; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Amemiya T; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Shimizu Y; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Shirakawa T; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
  • Kato D; Department of Urology, Teikyo University Hospital, Mizonokuchi, 5-1-1, Futago, Takatsu-ku, Kawasaki City, Kanagawa Prefecture, 213-8507, Japan.
World J Surg Oncol ; 21(1): 37, 2023 Feb 06.
Article en En | MEDLINE | ID: mdl-36747242

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Carcinoma de Células Renales / Carcinoma de Células Escamosas / Carcinoma de Pulmón de Células no Pequeñas / Procedimientos Quirúrgicos Robotizados / Neoplasias Renales / Neoplasias Pulmonares / Neoplasias Primarias Múltiples Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Surg Oncol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Carcinoma de Células Renales / Carcinoma de Células Escamosas / Carcinoma de Pulmón de Células no Pequeñas / Procedimientos Quirúrgicos Robotizados / Neoplasias Renales / Neoplasias Pulmonares / Neoplasias Primarias Múltiples Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Surg Oncol Año: 2023 Tipo del documento: Article